1. Contractors
  2. Abviro LLC

Abviro LLC

Federal contractor · Research and Development in Biotechnology

Abviro has 2 federal contracts of $100,000 or more active since October 2023, with $40.5M obligated, from 1 agency. 1 is still running, 1 ending within 18 months.

Contracts
2 since FY2024$40,510,113 obligated, contracts of $100,000 or more
Running now
1 contract
Biggest customer
National Institutes of Health$40.5M on 2 contracts
UEI
K3L6KXJ9B6M7Unique entity ID in SAM.gov
Source
USAspending.govUpdated Nov 17, 2026, 7:02 PM UTC

Running contracts

Soonest end first. An agency may compete the work again, extend the contract or move it to another vehicle.

ContractObligatedEndsState
To Conduct a Phase 2 Dengue Human Challenge Clinical Trial of Abviro Anti-Dengue Monoclonal Antibody (Mab) Av-1.National Institutes of Health · 75N93023C00055$11,335,102Dec 31, 2026in 1 monthMD

End dates are the current period of performance; options not yet exercised can extend them. Each contract links to its record on USAspending.gov.

Who they work for

AgencyAmount
National Institutes of Health2 contracts$40,510,113

What they sell

Where the work is

Place of workAmount
Maryland2 contracts$40,510,113

Source: USAspending.gov, prime contracts of $100,000 or more with an action since October 1, 2023. Department of Defense contracts appear there about 90 days after award. Other contracts ending soon at National Institutes of Health: see the list.

Get new notices like Abviro's work

New contract opportunities under NAICS 541711, research and development in biotechnology, the morning they appear. Free while in beta.

Free. We use your email only for these alerts and never share it. Privacy